Publications by the researcher in collaboration with Sergio Raposeiras Roubín (16)

2018

  1. Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium

    British Journal of Clinical Pharmacology, Vol. 84, Núm. 2, pp. 280-291

2016

  1. Change of concept about the regulation of angiotensin II-induced monocyte chemoattractant protein-1 production in human endothelial cells

    Vascular Pharmacology, Vol. 80, pp. 20-34

2015

  1. Advanced glycation end-products as long-term predictors of death and reinfarction after an acute coronary syndrome

    Biomarkers in Medicine, Vol. 9, Núm. 3, pp. 209-216

  2. Glycated human serum albumin induces NF-κB activation and endothelial nitric oxide synthase uncoupling in human umbilical vein endothelial cells

    Journal of Diabetes and its Complications, Vol. 29, Núm. 8, pp. 984-992

  3. Key structural and functional differences between early and advanced glycation products

    Journal of Molecular Endocrinology, Vol. 56, Núm. 1, pp. 23-37

2013

  1. Current status of NADPH oxidase researchin cardiovascular pharmacology

    Vascular Health and Risk Management, Vol. 9, Núm. 1, pp. 401-428

  2. Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome

    PLoS ONE, Vol. 8, Núm. 9

  3. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 117-122

  4. Statins modulate feedback regulation mechanisms between advanced glycation end-products and C-reactive protein: Evidence in patients with acute myocardial infarction

    European Journal of Pharmaceutical Sciences, Vol. 49, Núm. 4, pp. 512-518

2012

  1. Advanced glycation end products: A mysterious shadow beyond the relationship between HbA1c and atrial fibrillation

    International Journal of Cardiology, Vol. 157, Núm. 3, pp. 441

  2. Evidence for a role of advanced glycation end products in atrial fibrillation

    International Journal of Cardiology, Vol. 157, Núm. 3, pp. 397-402

  3. Is glycated hemoglobin an accurate enough predictor of subclinical myocardial injury or a simple precursor of advanced glycation end products?

    Journal of the American College of Cardiology

  4. Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report

    Cardiovascular Diabetology, Vol. 11

2011

  1. Productos de glicación avanzada: nuevo marcador de disfunción renal en pacientes con insuficiencia cardíaca crónica

    Medicina Clinica, Vol. 136, Núm. 12, pp. 513-521

  2. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of seattle heart failure score

    American Journal of Cardiology, Vol. 107, Núm. 6, pp. 938-944

2010

  1. Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels

    European Journal of Heart Failure, Vol. 12, Núm. 10, pp. 1092-1100